688606 奥泰生物
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资21,897--0000
投资性房地产13,618-0.66%13,7099,33500
固定资产244,473-1.70%248,698250,46698,62255,190
在建工程595,71122.01%488,25442,29982,37411,620
无形资产109,853-0.53%110,43493,02728,11928,790
商誉0--0000
其他非流动资产89,427-4.37%93,514110,521131,05230,330
1,074,98012.61%954,610505,648340,166125,930

流动资产
货币资金1,240,843-5.82%1,317,5531,981,8432,179,315285,639
应收账款87,786-12.97%100,870138,663208,199163,435
存货161,876-14.17%188,595193,660383,841123,726
其他流动资产1,575,3561.35%1,554,4311,875,009896,824452,379
3,065,860-3.02%3,161,4484,189,1743,668,1781,025,179

流动负债
短期借款0--0000
应付票据0--0000
应付帐款105,92636.49%77,609171,172360,65162,004
其他流动负债180,000-8.42%196,554339,580353,553116,441
285,9274.29%274,163510,753714,204178,445
流动资产净值2,779,934-3.72%2,887,2853,678,4222,953,974846,734
资产总额减流动负债3,854,9140.34%3,841,8954,184,0703,294,140972,664

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债12,12717.32%10,33713,44320,5030
12,12717.32%10,33713,44320,5030

总权益
    实收股本79,2810.00%79,28153,90453,90440,404
    储备项目3,759,3350.30%3,747,9684,112,3233,219,733932,260
股东权益3,838,6160.30%3,827,2494,166,2273,273,637972,664
非控股权益4,171-3.20%4,3094,40000